Valor202020212022202320242025TTMGastos comerciales, generales y administrativos59.69 M86.16 M121.47 M136.37 M139.59 M136.37 M134.72 MInvestigación y desarrollo64.69 M90.9 M126.37 M181.77 M201.78 M173.14 M171.12 MBeneficio operativo-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-164.8 MTotal de ingresos no operativos34.62 M10.63 M-2.31 M220.37 M23.59 M64.57 M62.64 MGastos por intereses, netos de intereses capitalizados000000—Ingresos no operativos, una vez deducidos los gastos por intereses34.62 M10.63 M-6.26 M200.67 M5.68 M48.17 M47.78 MIngresos/gastos extraordinarios——3.95 M19.69 M17.9 M16.4 M14.86 MBeneficio antes de impuestos-26.29 M-100.81 M-149.13 M42.92 M-185.71 M-102.33 M-102.16 MParticipación en los beneficios4.11 M-1.78 M11.82 M147.21 M00—Impuestos345 K411 K63 K2.2 M1.41 M939 K1.32 MParticipación minoritaria-2.17 M-826 K-3 0000———Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MOperaciones suspendidas———————Beneficio neto-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-24.46 M-100.39 M-149.19 M40.72 M-187.12 M-103.27 M-103.48 MBeneficio básico por acción——-2.10.57-2.57-1.41-1.4Beneficio por acción diluido——-2.10.54-2.57-1.41-1.4Número medio de acciones ordinarias——71.17 M71.78 M72.67 M73.44 M—Acciones diluidas——71.17 M74.99 M72.67 M73.44 M—EBITDA-57.26 M-108.6 M-142.47 M-171.9 M-203.14 M-160.87 M-158.89 MEBIT-60.92 M-111.44 M-146.82 M-177.45 M-209.3 M-166.9 M-164.8 MCosto de los ingresos44.62 M72.31 M79.93 M75.97 M75.46 M113.25 M113.87 MOtros costes de producción———————Amortización y depreciación (flujo de caja)3.66 M2.85 M4.34 M5.55 M6.16 M6.02 M5.91 M
Schrodinger, Inc. - Common Stock
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.